THERATECHNOLOGIES INC. 12,500,000 Shares of Common Stock (no par value per share) Underwriting AgreementTheratechnologies Inc. • October 27th, 2023 • Pharmaceutical preparations • New York
Theratechnologies Inc., a corporation formed under the Companies Act (Québec) and continued under the Business Corporations Act (Québec) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 12,500,000 its common shares, no par value per share (the “Shares”). The 12,500,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,875,000 Shares pursuant to such option, which are hereinafter collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. The Underwriters agree that the sale of Offere
